×

Register now for full access to all the content

First Name
Last Name
Company Name
Title
Country
Thank you for registering!
Error - something went wrong!
   

Designing Trials Payers Can Trust

August 22, 2017

Payers are becoming harder to please as budgets are squeezed and competition grows. Drugs have to be effective and this effectiveness must be evidenced and communicated clearly. The challenge is to design a trial payers can trust.

Analyzing the reasons products were approved or rejected at the reimbursement stage places PAREXEL in the advantageous position of being able to help clients learn from the mistakes of others. 

For the best results: 

• Don’t repeat the mistakes of others 
• Use early economic models 
• Applying payer-preferred endpoints in trials 
• Offering payers better data that is relevant to them 
• Keeping regulatory and commercial stakeholders in mind at the trial design stage to get them on your side 

Previous Flipbook
Stepping Into The Future of Pharmacovigilance
Stepping Into The Future of Pharmacovigilance

Read this Whitepaper to find out more about Knowledge Process Outsourcing!

Next Flipbook
Beyond Borders: Achieving Global Value From Local Observational Research
Beyond Borders: Achieving Global Value From Local Observational Research

Find out more about balanced observational research strategies here!